Kenneth W. Locke, Chief Scientific Officer at Neothetics, Inc. (NEOT), sold 598 shares at $1.26 ($753) on 2015-12-17, disclosed to the SEC on 2015-12-21.
Open-market sale of $753 NEOT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.